Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 10/20 | 0.54 |
| ▸ | CSNK1A1 | P48729 | 2/20 | 0.54 |
| ▸ | IKZF2 | Q9UKS7 | 9/20 | 0.44 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.44 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.44 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31403758 | 0.88 | CRBN (0.49) | CRBNCSNK1A1IKZF2GSPT1DDB1 | |
| SCHEMBL31403590 | 0.88 | CRBN (0.54) | CRBNCSNK1A1IKZF2 | |
| SCHEMBL31403539 | 0.85 | CRBN (0.51) | CRBNCSNK1A1IKZF2GSPT1DDB1 | |
| SCHEMBL31403614 | 0.82 | CRBN (0.55) | CRBNCSNK1A1IKZF2 | |
| SCHEMBL31403715 | 0.80 | CRBN (0.47) | CRBNCSNK1A1IKZF2GSPT1DDB1 | |
| SCHEMBL31159156 | 0.78 | CRBN (0.62) | CRBNCSNK1A1IKZF2GSPT1DDB1 | |
| SCHEMBL31158945 | 0.76 | CRBN (0.82) | CRBNCSNK1A1IKZF2GSPT1DDB1 | |
| SCHEMBL31158788 | 0.76 | CRBN (0.60) | CRBNCSNK1A1IKZF2HDAC3HDAC1 | |
| SCHEMBL22713505 | 0.75 | CRBN (0.63) | CRBNCSNK1A1IKZF2GSPT1DDB1 | |
| SCHEMBL31289139 | 0.75 | CRBN (0.65) | CRBNCSNK1A1IKZF2GSPT1DDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025076284-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | DELPHIA THERAPEUTICS, INC. (US) | 2025-04-10 | — | — | WO | disclosed |